FROM THE NEWS FEED
Psychedelic Alpha’s Josh Hardman speaks with newly appointed Helus Pharma CEO Michael Cola in a brief Q&A on execution, regulatory rigor, and scaling serotonergic CNS medicines.
Continue to the original publication for the complete article.
KEEP EXPLORING
At the Psychedelic Healthcare Forum, which took place in New York City last Thursday and was co-hosted by Psychedelic...
At The Psychedelic Healthcare Forum that we co-hosted last Thursday in New York, our Editor Josh Hardman sat down wit...
Psychedelics are no magic wand or silver bullet. However, in partnership with talk therapy, physical therapy, and oth...
Here’s what first time journeyers are saying about their psychedelic experience, in partnership with Psychedelic Pass...
Here’s what first time journeyers are saying about their psychedelic experience, in partnership with Psychedelic Pass...
There are many factors that can affect your journey, from set and setting to substance and dosage. At Psychedelic Pas...
Personal growth is a lifelong process. We've heard from so many people that, after years of other avenues, a psychede...
Again and again, we find that psychedelics can be the missing element that help people to heal and recover from past ...